Dear All,I've written before about the Vivli AMR Surveillance Data Challenge that seeks creative ways to reuse MICs from surveillance datasets (the 24 April 2023 newsletter covered the 2023 Challenge; the 15 June 2024 newsletter flagged the 2024 Challenge). As a reminder, Vivli is a clinical data sharing platform that was created in 2013 from a project by the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard. Funded by the Pfizer, Paratek, GARDP and Vivli, the Vivli challenge sought innovative re-use of surveillance data shared by GSK, Johnson & Johnson, Pfizer, Shionogi, Paratek, and Venatorx via the Vivli AMR Register.The 2024 Challenge has announced seven outstanding awardees selected from applications by 55 teams with team members from 27 different countries! The Grand Prize went to a team from the University of Oxford for their project “Advancing monitoring and prediction of antimicrobial resistance trajectories using flexible spatiotemporal modelling: A roadmap for early warning systems” by using the Pfizer ATLAS dataset of >900,000 isolates of 324 different bacterial species containing MIC values for 49 different antibiotics from 83 countries. The goal of the project is to enhance the ability to forecast AMR dynamics accurately, thereby supporting policymakers in formulating and adjusting AMR National Action Plans effectively. Impressive!Go to https://amr.vivli.org/data-challenge/finalist-and-award-winning-solutions/ to explore all the innovative...